Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA - Multiple System Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07644013
What this trial is testing

Prospective Multicenter Registry Study of Multiple System Atrophy in China

Who this might be right for
Multiple System AtrophyParkinson's DiseaseAtypical Parkinsonism
Peking University First Hospital 214
Testing effectiveness (Phase 2)Ended earlyNCT00547911
What this trial is testing

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

Who this might be right for
Parkinson DiseaseMultiple System AtrophyAutonomic Nervous System Diseases
National Institute of Neurological Disorders and Stroke (NINDS) 14
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Not applicableLooking for participantsNCT06841198
What this trial is testing

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

Who this might be right for
Spinal Cord Injuries (SCI)Orthostatic Hypotension, DysautonomicCardiovascular+1 more
Kessler Foundation 15
Not applicableStudy completedNCT02761707
What this trial is testing

Biomarkers in Neural Disorders

Who this might be right for
Parkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear Palsy+6 more
University of Pennsylvania 54
Not applicableStudy completedNCT04608604
What this trial is testing

Mobility in Atypical Parkinsonism: a Trial of Physiotherapy

Who this might be right for
Multiple System Atrophy, Parkinson Variant (Disorder)Parkinson DiseaseProgressive Supranuclear Palsy
Victoria Sidoroff 180
Not applicableLooking for participantsNCT03174938
What this trial is testing

The Swedish BioFINDER 2 Study

Who this might be right for
DementiaAlzheimer DiseaseParkinson Disease+10 more
Skane University Hospital 2,950
Early research (Phase 1)Active Not RecruitingNCT05698017
What this trial is testing

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)

Who this might be right for
Multiple System AtrophyMSA - Multiple System Atrophy
Cytora Ltd. 10
Very early researchLooking for participantsNCT07640542
What this trial is testing

Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase

Who this might be right for
Parkinson Disease (PD)MSA - Multiple System AtrophyHealthy Adult Participants
MODAG GmbH 9
Not applicableUnknownNCT04617873
What this trial is testing

DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism

Who this might be right for
Multiple System Atrophy, Parkinson Variant (Disorder)
zhangyuqing 20
Large-scale testing (Phase 3)Looking for participantsNCT07446894
What this trial is testing

MSA-01 in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Tokyo University 140
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Not applicableEnrolling By InvitationNCT07081841
What this trial is testing

AB-1005 Long-Term Follow-up Study

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy, Parkinson Variant
AskBio Inc 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT05923866
What this trial is testing

ONO-2808 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Ono Pharmaceutical Co., Ltd. 92
Not applicableNot Yet RecruitingNCT07036939
What this trial is testing

Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Ruijin Hospital 46
Not applicableEnded earlyNCT02445469
What this trial is testing

Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+1 more
University Hospital, Montpellier 130
Not applicableStudy completedNCT05819957
What this trial is testing

Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 15
Not applicableStudy completedNCT06738862
What this trial is testing

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

Who this might be right for
α-synucleinopathyParkinson's Disease (PD)Multiple System Atrophy+2 more
Ruijin Hospital 55
Next Page